中国卒中杂志 ›› 2024, Vol. 19 ›› Issue (7): 803-808.DOI: 10.3969/j.issn.1673-5765.2024.07.011

• 论著 • 上一篇    下一篇

药物涂层球囊与普通球囊血管成形术治疗症状性颅内动脉粥样硬化性狭窄的安全性和预后对比研究

李彦江1,刘彤晖1,田惠2,孙岩1,张勇1   

  1. 1 青岛 266000 青岛大学附属医院神经介入科

    2 青岛大学附属医院介入手术室

  • 收稿日期:2023-03-20 出版日期:2024-07-20 发布日期:2024-07-20
  • 通讯作者: 张勇 bravezhang@126.com

Comparative Study on the Safety and Prognosis of Drug-Coated Balloon Angioplasty and Conventional Balloon Angioplasty in the Treatment of Symptomatic Intracranial Atherosclerotic Stenosis

LI Yanjiang1, LIU Tonghui1, TIAN Hui2, SUN Yan1, ZHANG Yong1   

  1. 1 Department of Neurointervention, The Affiliated Hospital of Qingdao University, Qingdao 266000, China

    2 Interventional Operation Room, The Affiliated Hospital of Qingdao University, Qingdao 266000, China

  • Received:2023-03-20 Online:2024-07-20 Published:2024-07-20
  • Contact: ZHANG Yong, E-mail: bravezhang@126.com

摘要:

目的       对比分析药物涂层球囊(drug-coated balloonDCB)和普通球囊血管成形术治疗症状性颅内动脉粥样硬化性重度狭窄患者的安全性和预后。

方法       回顾性分析20203月—20224月在青岛大学附属医院进行治疗的症状性颅内动脉粥样硬化性重度狭窄患者,按照治疗方式的不同分为DCB组和普通球囊组。比较两组患者的一般临床资料、疗效和安全性终点,包括围手术期并发症、临床结局和影像随访结果。

结果       研究共纳入49例患者,其中DCB30例,普通球囊组19例。两组的基线资料、围手术期并发症、术后6个月内再发卒中率、再狭窄率及死亡率差异均无统计学意义(P>0.05);6个月随访DCB组狭窄程度为14.50%9.55%23.42%),低于普通球囊组的30.00%15.42%37.61%),差异有统计学意义(P0.027)。

结论       与普通球囊相比,DCB治疗症状性颅内动脉粥样硬化性重度狭窄是安全的,可以有效降低目标血管再狭窄的进展。

文章导读: 再狭窄是血管介入治疗症状性颅内动脉粥样硬化性狭窄后再发卒中的重要原因。与普通球囊相比,药物涂层球囊可以降低术后再狭窄风险。

关键词: 药物涂层球囊; 血管成形术; 颅内动脉粥样硬化; 缺血性卒中; 脑血管狭窄

Abstract:

Objective  To compare the safety and prognosis of drug-coated balloon (DCB) angioplasty and conventional balloon angioplasty in treating symptomatic intracranial atherosclerotic stenosis.

Methods  The patients with symptomatic severe intracranial atherosclerotic stenosis who were treated at The Affiliated Hospital of Qingdao University from March 2020 to April 2022 were retrospectively analyzed. Patients were divided into the DCB group and the conventional balloon group according to the treatment method. The general clinical data, efficacy, and safety endpoints, including perioperative complications, clinical outcomes, and imaging results during follow-up, were compared between the two groups.

Results  A total of 49 patients were included in the study, including 30 in the DCB group and 19 in the conventional balloon group. There were no significant differences in baseline data and perioperative complications, as well as stroke recurrence rate, restenosis rate and mortality within 6 months after surgery between the two groups (P>0.05). The DCB group exhibited a lower degree of restenosis at 14.50% (9.55%-23.42%), as compared to 30.00% (15.42%-37.61%) in the conventional balloon group, with a statistically significant difference (P=0.027).

Conclusions  In comparison to conventional balloon treatment, DCB treatment is considered safe for symptomatic severe intracranial atherosclerotic stenosis and can effectively reduce the progress of target vessel restenosis.

Key words: Drug-coated balloon; Angioplasty; Intracranial atherosclerosis; Ischemic stroke; Cerebrovascular stenosis

中图分类号: